Editor’s note: On Oct. 26, 2020, the ACR submitted comments opposing the proposed change. The Immigrations and Customs Enforcement (ICE) Bureau issued a notice of proposed rulemaking on Sept. 25 that would change the admission period of academic student and exchange visitor aliens, as well as representatives of foreign information media, from duration of status…
Rep. Kim Schofield’s path to the Georgia House of Representatives started with her lupus diagnosis 20 years ago.
As of Oct. 1, UnitedHealthcare (UHC) requires that patients fail to respond to both FDA-approved rituximab biosimilars prior to receiving approval for rituximab. Exception: Rituximab-pvvr (Ruxience) is not FDA approved for rheumatoid arthritis.
The ACR submitted comments to the Institute for Clinical & Economic Review outlining key considerations that should inform independent assessment of the efficacy and cost-effectiveness of medical therapies for lupus nephritis.
RheumPAC will once again conduct a matching campaign in November, coinciding with ACR Convergence 2020. During this time, all donations to RheumPAC will be amplified by leaders from the College, who will match various dollar amounts for each contribution. Additionally, many will donate a larger amount for first-time investors. Last year, matching funds contributed $91…
Attendees at the daylong workshop will learn about key evaluation and management code changes coming in 2021 that affect rheumatologists and rheumatology professionals.
A panel of rheumatologists will provide updates on MACRA’s quality measure requirements and the ACR’s progress in quality measurement in rheumatology in a session at ACR Convergence 2020.
Pregnancy complications are common in lupus and antiphospholipid syndrome (APS), but can we predict and prevent them? The Rheumatology Research Foundation Memorial Lectureship to Honor Shaun Ruddy, MD, will review the predictors and mechanisms of pregnancy complications, as well as potential interventions for preventing pregnancy complications associated with lupus and APS. Watch for it on…
This session at ACR Convergence will focus on early biomarkers for diagnostic and prognostic purposes, as well as the description of current treatment guidelines from multiple societies. The speakers will discuss the role of repeated biopsy to assess response and maintenance therapy, and describe some promising new therapies under development. Watch for it on Sunday,…
Patients with RA and OA have joint pain, and pain is the primary reason patients seek care. The mechanisms responsible for the pain are now just beginning to be understood. This session, on Nov. 6, 4 p.m. EST, will cover the mechanisms responsible for the development of pain in both inflammatory and degenerative arthritis.